This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Our oncology portfolio

Supporting documentation

KEYTRUDA® (pembrolizumab)
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

LYNPARZA, Ovarian (tablets) - Great Britain
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

LYNPARZA, Ovarian (capsules) - Great Britain
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

LYNPARZA, Prostate (tablets) - Great Britain
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

LYNPARZA, Ovarian (tablets) – Northern Ireland
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

LYNPARZA, Ovarian (capsules) – Northern Ireland
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

LYNPARZA, Prostate (tablets) – Northern Ireland
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

GB-PDO-01693 | Date of Preparation: September 2021